GOTHENBURG, Sweden, April 11, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), today announced that the company’s annual report and corporate governance report for the financial year 2024 are now available, in Swedish as well as an English translation, on the company’s website, www.isofolmedical.com. The information in the press release is intended for investors. […]
GOTHENBURG, Sweden, April 16, 2024 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), today announced that the company’s annual report and corporate governance report for the financial year 2023 are now available, in Swedish, on the company’s website, www.isofolmedical.com. The information in the press release is intended for investors. For further information, please contactIsofol Medical
GOTHENBURG, Sweden, April 6, 2023 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), today announced that the company’s annual report and corporate governance report for the financial year 2022 are now available, in Swedish, on the company’s website, www.isofolmedical.com. The information in the press release is intended for investors. For further information, please contact Isofol
GOTHENBURG, Sweden, April 27, 2022 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), today announced that the company’s annual report and corporate governance report for the financial year 2021 are now available on the company’s website, www.isofolmedical.com (https://isofolmedical.com/investors/financial-reports/). For further information, please contact Isofol Medical AB (publ) Jarl Ulf Jungnelius, M.D., Chief Executive Officer E-mail: jungnelius@isofolmedical.com
